期刊论文详细信息
Frontiers in Medicine | |
Simvastatin in the Prevention of Recurrent Pancreatitis: Design and Rationale of a Multicenter Triple-Blind Randomized Controlled Trial, the SIMBA Trial | |
Bechien U. Wu1  Pedro Zapater2  Pramoud K. Garg3  Georgios I. Papachristou4  Karina Cárdenas-Jaén5  Alicia Vaillo-Rocamora5  Enrique de-Madaria5  Vikesh K. Singh6  Ángel Gracia7  | |
[1] Center for Pancreatic Care, Division of Gastroenterology, Kaiser Permanente Los Angeles Medical Center, Los Angeles, CA, United States;Department of Clinical Pharmacology, Alicante University General Hospital, Alicante Institute for Health and Biomedical Research (ISABIAL), Alicante, Spain;Department of Gastroenterology, All India Institute of Medical Sciences, New Delhi, India;Division of Gastroenterology, Hepatology and Nutrition, Ohio State University Wexner Medical Center, Columbus, OH, United States;Pancreatic Unit, Department of Gastroenterology, Alicante University General Hospital, Alicante Institute for Health and Biomedical Research (ISABIAL), Alicante, Spain;Pancreatitis Center, Division of Gastroenterology, Johns Hopkins Medical Institutions, Baltimore, MD, United States;Pharmacy Department, Alicante University General Hospital, Alicante Institute for Health and Biomedical Research (ISABIAL), Alicante, Spain; | |
关键词: hydroxymethylglutaryl-CoA reductase inhibitors; statins; simvastatin; acute pancreatitis; chronic pancreatitis; recurrent; idiopathic; prevention; | |
DOI : 10.3389/fmed.2020.00494 | |
来源: Frontiers | |